A Study of Breast Cancer Risk Factors and Outcomes of People in Florida
Launched by MEMORIAL SLOAN KETTERING CANCER CENTER · Jan 16, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding why some people are more likely to develop breast cancer than others and how different factors may affect their outcomes. Researchers are looking at various risk factors and the results of people with breast cancer and those without it. The study is currently recruiting participants, and anyone aged 18 and older who has been seen at specific breast radiology clinics in Florida may be invited to join.
To participate, you should be someone who has had a breast exam and may need a biopsy, as identified by your healthcare provider. Anyone under 18 years old or unable to complete a survey for the study will not be eligible. If you decide to take part, you can expect to complete a survey that helps researchers gather important information about your health and experiences related to breast cancer. This study aims to improve our understanding of breast cancer risk and outcomes, which could help in developing better prevention and treatment strategies in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with BIRADS 0-5, seen in breast radiology clinic at University of Miami (UM), Sylvester Comprehensive Cancer Center (SCCC), Jackson Health Systems (JHS) for biopsy.
- • Any new breast patient seen at UM/SCCC or JHS will be invited to participate in the study.
- • Men and women 18 years of age and older are eligible to participate in the study.
- Exclusion Criteria:
- • Patients who are less than 18 years of age will be considered ineligible.
- • Patients unable to complete the survey.
About Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center (MSKCC) is a world-renowned institution dedicated to cancer treatment, research, and education. As a leading clinical trial sponsor, MSKCC focuses on advancing innovative cancer therapies through rigorous scientific investigation and collaboration. The center's multidisciplinary team of experts employs cutting-edge methodologies to design and conduct trials that aim to improve patient outcomes and enhance understanding of cancer biology. With a commitment to translating research findings into clinical practice, MSKCC plays a pivotal role in shaping the future of oncology care and ensuring that patients have access to the latest therapeutic advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Miami, Florida, United States
New York, New York, United States
Los Angeles, California, United States
Patients applied
Trial Officials
Neha Goel, MD, MPH
Principal Investigator
Memorial Sloan Kettering Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported